With solid organic revenue growth of 9% in Q1 2014/15, Chr. Hansen has started the year well
Says CEO Cees de Jong, 'With solid organic revenue growth of 9% in Q1 2014/15, Chr. Hansen has started the year well. The Cultures & Enzymes Division (7% organic growth) performed in line with our long-term expectations and the Health & Nutrition Division (29%) delivered very strong growth albeit on weak comparables. The Natural Colors Division (4%) grew below expectation.'
He added: 'The implementation of our Nature’s No. 1 strategy continues. We have accelerated our research and development efforts within biological plant protection and we have strengthened the organisation in China to support our new go-to-market strategy for cultures and enzymes. Finally, the implementation of the new dedicated sales and application organization in the Natural Colors Division is on track and we expect the performance of the division to improve during the year.'
'We reiterate our expectations for 2014/15 of organic revenue growth of 7-9% and an EBIT margin before special items above 26.5%.'
Highlights Q1 2014/15
The outlook for 2014/15 is unchanged from the announcement of 22 October 2014. Organic revenue growth is expected to be 7-9%.